Membrane receptors mediating thyroid hormone action

Area of Science:

• Endocrinology
• Cell Biology
• Molecular Signaling

Background:

• Thyroid hormone traditionally acts via nuclear receptors.
• A novel cell surface receptor for thyroid hormone has been identified on integrin alphaVbeta3.
• This receptor initiates rapid signaling cascades.

Purpose of the Study:

• To investigate the signaling pathways activated by the thyroid hormone cell surface receptor.
• To explore the implications of this receptor for therapeutic applications.
• To demonstrate the feasibility of modifying thyroid hormone to target cell surface actions.

Main Methods:

• Utilized human cell lines to study thyroid hormone receptor interactions.
• Investigated the activation of the mitogen-activated protein kinase (MAPK) signaling pathway.
• Analyzed downstream effects including ion pump stimulation and nuclear events.

Main Results:

• Identified integrin alphaVbeta3 as a thyroid hormone cell surface receptor.
• Demonstrated MAPK pathway activation by this receptor.
• Observed MAPK-dependent stimulation of ion pumps and nuclear events, including receptor phosphorylation and coactivator recruitment.
• Linked these events to thyroid hormone-induced angiogenesis and tumor cell growth.

Conclusions:

• Thyroid hormone exerts rapid, non-genomic effects through cell surface integrin alphaVbeta3.
• This receptor mediates crucial cellular processes like angiogenesis and tumor growth.
• Structural modification of thyroid hormone offers a strategy to selectively modulate cell surface receptor activity, potentially leading to novel therapeutic interventions.